An administrative court on Wednesday ruled in favor of Biogen Inc in a battle with generic drugmaker Mylan NV over a patent on its multiple sclerosis drug Tecfidera. Reuters Health News

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Time limit is exhausted. Please reload CAPTCHA.